[ 1 ] Simon A, Wilhelmi M, Steinhoff G, et al. Cardiac valve endothelial cells: relevance in the long-term function of biologic valve prostheses[J]. J Thorac Cardiovasc Surg, 1998, 116(4):609-616
[ 2 ] 董念国, 史嘉玮, 胡平. 组织工程心脏瓣膜支架的研究现状和发展趋势[J]. 中华实验外科杂志, 2007, 24(3):261-262.
[ 3 ] Uygun BE, Soto-Gutierrez A, Yagi H, et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix[J]. Nat Med, 2010, 16(7):814-820.
[ 4 ] 王鹏, 张刚, 李毅, 等. 去细胞组织工程异种瓣膜支架制备方法的比较研究[J]. 国际心血管病杂志, 2007, 13(5):374-377.
[ 5 ] 许倩, 李顺, 陈善泽. 巨噬细胞极化与炎症性疾病[J]. 国外医药:抗生素分册, 2018, 39(1):80-85.
[ 6 ] 李潇, 朱平. 心脏瓣膜罕见疾病研究进展[J]. 现代医药卫生, 2017, 33(20):3128-3130.
[ 7 ] 刘天起, 王东, 李培杰, 等. 原位心脏移植治疗终末期心脏病25例临床分析[J]. 中华移植杂志, 2013, 7(1):10-13.
[ 8 ] Schenke-Layland K, Vasilevski O, Opitz F, et al. Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves[J]. J Struct Biol, 2003, 143(3):201-208.
[ 9 ] Cebotari S, Mertsching H, Kallenbach K, et al. Construction of autologous human heart valves based on an acellular allograft matrix[J]. Circulation, 2002, 106(13S):I63-I68.
[10] Rahimtoola SH. The year in valvular heart disease[J]. J Am Coll Cardiol, 2013, 61(12):1290-1301.
[11] Neuenschwander S, Hoerstrup SP. Heart valve tissue engineering[J]. Transpl Immunol, 2004, 12(3/4):359-365.
[12] Flanagan TC, Pandit A. Living artificial heart valve alternatives: a review[J]. Eur Cell Mater, 2003, 6:28-45.